L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own TAK

Takeda Pharmaceutical Co LTD in the Q2 2026 filings. At least 1 of the 91 current managers on file reported a position, worth $309m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
1
at least, of 91 current
Combined value
$309m
as reported
Opened
0
new this quarter
Added to
1
already held
Trimmed or sold out
0
0 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
Capital Research Global Investors
Long-only · $717bn book
$309m0.0%19,297,680-$45m+193,461Added

Ownership through time

At least 3 of the 95 managers whose filings are on file listed TAK in Q2 2026, against 3 in Q4 2018. The same number as in Q1 2026.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
0612Q4 2018: 3Q1 2019: 1219Q2 2019: 6Q3 2019: 9Q4 2019: 6Q1 2020: 420Q2 2020: 4Q3 2020: 4Q4 2020: 5Q1 2021: 421Q2 2021: 4Q3 2021: 4Q4 2021: 2Q2 2022: 3Q3 2022: 3Q4 2022: 5Q1 2023: 523Q2 2023: 5Q3 2023: 4Q4 2023: 5Q1 2024: 324Q2 2024: 4Q3 2024: 3Q4 2024: 3Q1 2025: 325Q2 2025: 2Q3 2025: 2Q4 2025: 4Q1 2026: 326Q2 2026: 3
  • Q4 2018: 3
  • Q1 2019: 12
  • Q2 2019: 6
  • Q3 2019: 9
  • Q4 2019: 6
  • Q1 2020: 4
  • Q2 2020: 4
  • Q3 2020: 4
  • Q4 2020: 5
  • Q1 2021: 4
  • Q2 2021: 4
  • Q3 2021: 4
  • Q4 2021: 2
  • Q2 2022: 3
  • Q3 2022: 3
  • Q4 2022: 5
  • Q1 2023: 5
  • Q2 2023: 5
  • Q3 2023: 4
  • Q4 2023: 5
  • Q1 2024: 3
  • Q2 2024: 4
  • Q3 2024: 3
  • Q4 2024: 3
  • Q1 2025: 3
  • Q2 2025: 2
  • Q3 2025: 2
  • Q4 2025: 4
  • Q1 2026: 3
  • Q2 2026: 3
Their combined reported value
$0$579m$1bnQ4 2018: $83mQ1 2019: $1.2bn19Q2 2019: $721mQ3 2019: $718mQ4 2019: $645mQ1 2020: $362m20Q2 2020: $395mQ3 2020: $423mQ4 2020: $549mQ1 2021: $699m21Q2 2021: $476mQ3 2021: $410mQ4 2021: $111mQ2 2022: $69mQ3 2022: $68mQ4 2022: $208mQ1 2023: $349m23Q2 2023: $353mQ3 2023: $311mQ4 2023: $374mQ1 2024: $228m24Q2 2024: $243mQ3 2024: $236mQ4 2024: $271mQ1 2025: $256m25Q2 2025: $257mQ3 2025: $253mQ4 2025: $355mQ1 2026: $467m26Q2 2026: $410m
  • Q4 2018: $83m
  • Q1 2019: $1.2bn
  • Q2 2019: $721m
  • Q3 2019: $718m
  • Q4 2019: $645m
  • Q1 2020: $362m
  • Q2 2020: $395m
  • Q3 2020: $423m
  • Q4 2020: $549m
  • Q1 2021: $699m
  • Q2 2021: $476m
  • Q3 2021: $410m
  • Q4 2021: $111m
  • Q2 2022: $69m
  • Q3 2022: $68m
  • Q4 2022: $208m
  • Q1 2023: $349m
  • Q2 2023: $353m
  • Q3 2023: $311m
  • Q4 2023: $374m
  • Q1 2024: $228m
  • Q2 2024: $243m
  • Q3 2024: $236m
  • Q4 2024: $271m
  • Q1 2025: $256m
  • Q2 2025: $257m
  • Q3 2025: $253m
  • Q4 2025: $355m
  • Q1 2026: $467m
  • Q2 2026: $410m

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Started in Q2 2026

No manager on file started a position.

Largest increases, by shares

Largest decreases, by shares

Left it

No manager on file is shown leaving it.

ManagerValue over timeFirst listedLargestQ2 2026
Capital Research Global InvestorsQ3 2019$354m$309m
Arrowstreet Capital LPQ4 2018$89m$60m
Renaissance Technologies LLCQ1 2020$102m$41m
Glenview Capital Management LLCQ1 2019$603mlast listed Q3 2021
ARK Investment Management LLCQ3 2020$342mlast listed Q4 2021
Baupost Group LLCQ1 2019$217mlast listed Q3 2019
Sachem Head Capital Management LPQ1 2019$121mlast listed Q1 2019
Millennium Management LLCQ1 2019$93mlast listed Q4 2023
Marshall Wace LLPQ1 2019$60mlast listed Q3 2019
Point72 Asset Management LPQ1 2019$43mlast listed Q2 2023
Maverick Capital LtdQ4 2018$35mlast listed Q4 2019
Tudor Investment CorpQ1 2019$26mlast listed Q4 2019
Hudson Bay Capital Management LPQ1 2019$20mlast listed Q3 2024

What TAK is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around TAK →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.